The Leadership Team at NeuroSense Therapeutics drives the strategic vision and operational effectiveness of the company as it advances innovative therapies for ALS and other neurodegenerative diseases. Comprising experts in research, clinical operations, finance, and regulatory affairs, this team collaborates to ensure efficient drug development, secure funding, and navigate complex regulatory landscapes while maintaining a strong focus on patient outcomes and scientific integrity.
View all